Directly conjugated antibodies for immunofluorescence

Find out more

Publishing research using ab7417? Please let us know so that we can cite the reference in this datasheet.

ab7417 has been referenced in 7 publications.

  • Principe S  et al. Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. J Proteome Res 11:2386-96 (2012). WB . PubMed: 22339264
  • Favaloro EJ  et al. The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150. Clin Chim Acta 220:81-90 (1993). PubMed: 7904544
  • Favaloro EJ  et al. CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated. Exp Hematol 21:1695-701 (1993). PubMed: 7902291
  • Favaloro EJ CD-13 ('gp150'; aminopeptidase-N): co-expression on endothelial and haemopoietic cells with conservation of functional activity. Immunol Cell Biol 69 ( Pt 4):253-60 (1991). PubMed: 1723966
  • Favaloro EJ  et al. Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33. Br J Haematol 69:163-71 (1988). PubMed: 2455535
  • Bradstock KF  et al. Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells. Pathology 17:392-9 (1985). PubMed: 3865147
  • Bradstock KF  et al. Myeloid progenitor surface antigen identified by monoclonal antibody. Br J Haematol 61:11-20 (1985). PubMed: 4052321

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"